BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7862138)

  • 1. The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras.
    Peacock JW; Chung S; Bristow RG; Hill RP; Benchimol S
    Mol Cell Biol; 1995 Mar; 15(3):1446-54. PubMed ID: 7862138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.
    Peacock JW; Benchimol S
    EMBO J; 1994 Mar; 13(5):1084-92. PubMed ID: 8131742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
    Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
    Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
    Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
    Syljuåsen RG; Krolewski B; Little JB
    Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.
    Bristow RG; Hu Q; Jang A; Chung S; Peacock J; Benchimol S; Hill R
    Oncogene; 1998 Apr; 16(14):1789-802. PubMed ID: 9583677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53.
    Storey A; Massimi P; Dawson K; Banks L
    Oncogene; 1995 Aug; 11(4):653-61. PubMed ID: 7651728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.
    Crook T; Fisher C; Vousden KH
    J Virol; 1991 Jan; 65(1):505-10. PubMed ID: 1845904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
    Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
    Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcript exhibiting homology to endogenous rat retroviral-like elements is regulated by p53.
    Gangopadhyay SB; Peacock JW; Benchimol S
    Oncogene; 1996 Dec; 13(12):2731-5. PubMed ID: 9000148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
    Song S; Gulliver GA; Lambert PF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation.
    Tsang NM; Nagasawa H; Li C; Little JB
    Oncogene; 1995 Jun; 10(12):2403-8. PubMed ID: 7784090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53.
    Vousden KH; Vojtesek B; Fisher C; Lane D
    Oncogene; 1993 Jun; 8(6):1697-702. PubMed ID: 8389035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
    Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
    Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.